The Secretome of Human Deciduous Tooth-Derived Mesenchymal Stem Cells Enhances In Vitro Wound Healing and Modulates Inflammation

Background/Objectives: Chronic wounds represent a significant clinical and public health challenge due to impaired tissue repair and high associated morbidity. This study investigates the therapeutic potential of the secretome derived from human mesenchymal stem cells obtained from the pulp of decid...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 17; no. 8; p. 961
Main Authors Payão, Thais Simião, Pellegrini, Vanessa, Morari, Joseane, Gonçalves, Gisele Mara Silva, de Godoy, Maria Carolina Ximenes, Gambero, Alessandra, Reis, Leonardo O., Velloso, Lício Augusto, Araújo, Eliana Pereira, Pascoal, Lívia Bitencourt
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.07.2025
MDPI
Subjects
Online AccessGet full text
ISSN1999-4923
1999-4923
DOI10.3390/pharmaceutics17080961

Cover

More Information
Summary:Background/Objectives: Chronic wounds represent a significant clinical and public health challenge due to impaired tissue repair and high associated morbidity. This study investigates the therapeutic potential of the secretome derived from human mesenchymal stem cells obtained from the pulp of deciduous teeth (hDP-MSCs) in promoting skin wound healing. Methods: After confirming the mesenchymal identity and multipotent differentiation potential of hDP-MSCs by using flow cytometry and histological staining, the effects of the secretome on human keratinocyte (HaCaT) cultures were evaluated. Results: Scratch assays, performed under high- and low-glucose conditions, demonstrated that the secretome significantly promoted keratinocyte migration and wound closure without compromising cell viability. Additionally, the secretome modulated the expression of key genes involved in inflammation and tissue regeneration, including IL-1β, TNF-α, TGF-β1, and VEGF-α, in a time-dependent manner. Under inflammatory conditions induced by lipopolysaccharide, co-treatment with the secretome significantly reduced TNF-α expression and increased TGF-β1 expression, suggesting an anti-inflammatory effect. Conclusions: These findings indicate the potential of the hDP-MSC-derived secretome as a promising cell-free therapeutic strategy capable of accelerating skin regeneration and modulating the inflammatory response during the wound healing process.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics17080961